- Home
- ABLV vs LVTX Comparison
ABLV vs LVTX Comparison
Compare ABLV & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABLV
- LVTX
- Stock Information
- Founded
- ABLV 2015
- LVTX 2016
- Country
- ABLV China
- LVTX Netherlands
- Employees
- ABLV N/A
- LVTX N/A
- Industry
- ABLV
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- ABLV
- LVTX Health Care
- Exchange
- ABLV Nasdaq
- LVTX Nasdaq
- Market Cap
- ABLV 38.1M
- LVTX 42.1M
- IPO Year
- ABLV N/A
- LVTX 2021
- Fundamental
- Price
- ABLV $0.65
- LVTX $1.01
- Analyst Decision
- ABLV
- LVTX Buy
- Analyst Count
- ABLV 0
- LVTX 3
- Target Price
- ABLV N/A
- LVTX $4.67
- AVG Volume (30 Days)
- ABLV 18.1K
- LVTX 159.9K
- Earning Date
- ABLV 01-01-0001
- LVTX 12-10-2024
- Dividend Yield
- ABLV N/A
- LVTX N/A
- EPS Growth
- ABLV 18.07
- LVTX N/A
- EPS
- ABLV 0.24
- LVTX N/A
- Revenue
- ABLV $148,999,819.00
- LVTX $7,345,000.00
- Revenue This Year
- ABLV N/A
- LVTX N/A
- Revenue Next Year
- ABLV N/A
- LVTX N/A
- P/E Ratio
- ABLV $3.07
- LVTX N/A
- Revenue Growth
- ABLV 2.58
- LVTX N/A
- 52 Week Low
- ABLV $0.55
- LVTX $0.96
- 52 Week High
- ABLV $3.94
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- ABLV 45.41
- LVTX 32.32
- Support Level
- ABLV $0.55
- LVTX $1.00
- Resistance Level
- ABLV $0.77
- LVTX $1.95
- Average True Range (ATR)
- ABLV 0.07
- LVTX 0.17
- MACD
- ABLV -0.01
- LVTX -0.06
- Stochastic Oscillator
- ABLV 48.83
- LVTX 6.00
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.